Back to search
FDAFDA · Food and drugs·Recall number D-0790-2022

Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59

Published May 4, 2022 · Recall initiated: April 12, 2022

Summary

FDA records drug Class III recall D-0790-2022, published May 4, 2022 and initiated April 12, 2022. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 97,975 vials; Lot: Lots: CCC210008, CCC210009, Exp. 01/23. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug: Out of specification for assay.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Health Packaging
Distributor
Alabama
Lot
Lots: CCC210008, CCC210009, Exp. 01/23
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cyanocobalamin Injection, USP, 1000 mcg per mL, For Intramuscular or Subcutaneous Use Only, 25 x 1 mL Vials, Rx only, Manufactured by: Eugia Pharma Specialties Limited, Hyderabad India for BluePoint Laboratories. NDC for Carton: 68001-509-60; NDC for vial: 68001-509-59 recalled?

Yes. FDA published recall D-0790-2022 on May 4, 2022. Reported hazard: Subpotent Drug: Out of specification for assay.

What should I do if I have this product?

Voluntary: Firm initiated · Letter